The cast of ShowStopper includes actors Digangana Suryavanshi, Tannaz Irani, and Bakhtiyaar Irani. The creators have consciously kept the content family-friendly, deliberately steering away from the common OTT tropes of violence, sensationalism, or adult content
In a push to raise public awareness around breast health, particularly breast cancer, DIISHA — the flagship digital healthcare pilot project by Ease of Doing Business (EoDB) — has partnered with MH Films to launch a web series titled *‘ShowStopper’*. The series, positioned as clean and socially conscious OTT content, aims to support early detection and screening efforts through accessible storytelling.
ShowStopper serves as an extension of DIISHA’s wider initiative to transform grassroots healthcare in India through digital tools. The series will address key issues surrounding breast health, to encourage more women to come forward for screening and early intervention.
“We’re dealing with a concerning reality: out of 196,000 annual breast cancer cases in India, around 60% result in fatalities—largely due to late diagnosis,” said Abhijeet Sinha, Project Director of the DIISHA pilot under EoDB. “This series intends to begin a family-level conversation on breast health and drive awareness in a relatable and responsible way.”
DIISHA, which stands for Digitally Integrated Infrastructure for Screening, Health Awareness, and Augmentation, is currently being piloted in 72 districts across 9 states. It involves over 90,000 ASHA workers and samples data from 1.25 crore individuals. The long-term vision is to build one of the world’s largest quantified and transparent healthcare databases, aimed at improving population health through tech-based interventions.
The cast of ShowStopper includes actors Digangana Suryavanshi, Tannaz Irani, and Bakhtiyaar Irani. The creators have consciously kept the content family-friendly, deliberately steering away from the common OTT tropes of violence, sensationalism, or adult content.
Director Manish Harishankar shared his journey of conceptualising the series, acknowledging initial scepticism from industry professionals who doubted whether a clean, issue-focused show could gain traction in the current OTT landscape. “This is not a glamour-heavy show — it’s a conversation starter, and that’s what makes it meaningful,” he said.
The series is scheduled for release in August 2025, aligned with World Breast Cancer Research Day, and is expected to premiere on a mainstream OTT platform.
